PM&R
Volume 1, Issue 10 , Pages 908-915 , October 2009

Prospective Pilot Study of Painful Lumbar Facet Joint Arthropathy after Intra-articular Injection of Hylan G-F 20

  • Michael J. DePalma, MD

      Affiliations

    • VCU Spine Center, Virginia Commonwealth University Department of Physical Medicine and Rehabilitation, 870 Stony Point Parkway, Suite 260, Richmond, VA 23235
    • Corresponding Author InformationAddress correspondence to: M.J.D.
  • ,
  • Jessica M. Ketchum, PhD

      Affiliations

    • Virginia Commonwealth University, Department of Biostatistics, Richmond, VA
  • ,
  • Evan D. Queler, MD

      Affiliations

    • Virginia Commonwealth University Spine Center, Department of Physical Medicine and Rehabilitation, Richmond, VA§
  • ,
  • Brian S. Trussell, MD

      Affiliations

    • Virginia Commonwealth University Spine Center, Department of Physical Medicine and Rehabilitation, Richmond, VA

Received 16 July 2009 ,Accepted 17 September 2009.

References 

  1. Marks RC, Houston T, Thulbourne T, et al. Facet joint injection and facet nerve block: A randomized comparison in 86 patients with chronic low back pain. Pain. 1992;49:325–328
  2. Ashton IK, Ashton BA, Gibson SJ, et al. Morphological basis for back pain: The demonstration of nerve fibers and neuropeptides in the lumbar facet joint capsule but not in ligamentum flavum. J Orthop Res. 1992;10:72–78
  3. Yamashita T, Cavanaugh JM, el-Bohy AA, et al. Mechanosensitive afferent units in the lumbar facet joint. J Bone Joint Surg [Am]. 1990;72:865–870
  4. Yamashita T, Cavanaugh JM, Ozaktay AC, et al. Effect of substance P on mechanosensitive units of tissues around facet joint. J Orthop Res. 1993;11:205–214
  5. Goldthwait JE. The lumbosacral articulation: An explanation of many cases of lumbago, sciatica, and paraplegia. Boston Med Surg J. 1911;164:265–372
  6. Schwarzer AC, Aprill CN, Derby R, et al. The false-positive rate of uncontrolled diagnostic blocks of the lumbar zygapophysial joints. Pain. 1994;58:195–200
  7. Manchikanti L, Manchikanti KN, Cash KA, et al. Age-related prevalence of facet-joint involvement in chronic neck and low back pain. Pain Physician. 2008;11:67–75
  8. Carette S, Marcoux S, Truchon R, et al. A controlled trial of corticosteroid injections into facet joints for chronic low back pain. N Engl J Med. 1991;325:1002–1007
  9. Lynch MC, Taylor AF. Facet joint injection for low back pain. J Bone Joint Surg Br. 1986;68:138–141
  10. Lilius G, Laasonen EM, Myllynen P, et al. Lumbar facet joint syndrome (A randomised clinical trial). J Bone Joint Surg Br. 1989;71:681–684
  11. Marks RC, Houston T, Thulbourne T. Facet joint injection and facet nerve block: A randomised comparison in 86 patients with chronic low back pain. Pain. 1992;49:325–328
  12. Nath S, Nath CA, Pettersson K. Percutaneous lumbar zygapophysial (facet) joint neurotomy using radiofrequency current, in the management of chronic low back pain: A randomized double-blind trial. Spine. 2008;33:1291–1297discussion 1298.
  13. Fuchs S, Erbe T, Fischer HE. Intraarticular hyaluronic acid versus glucocorticoid injections for nonradicular pain in the lumbar spine. J Vasc Interv Radiol. 2005;16:1493–1498
  14. Cleary M, Keating C, Poynton AR. Viscosupplementation in lumbar facet joint arthropathy: A pilot study. J Spinal Disord Tech. 2008;21:29–32
  15. Bogduk N. Evidence-informed management of chronic low back pain with facet injections and radiofrequency neurotomy. Spine J. 2008;8:56–64
  16. Kirkaldy-Willis WH. The pathology and pathogenesis of low back pain. In:  Kirkaldy-Willis WH editors. Managing Low Back Pain. New York: Churchill Livingstone; 1988;p. 49
  17. Fujiwara A, Tamai K, An HS, et al. The relationship between disc degeneration, facet joint osteoarthritis, and stability of the degenerative lumbar spine. J Spinal Disord. 2000;13:444–450
  18. Pozo MA, Balazs EA, Belmonte C. Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res. 1997;116:3–9
  19. Bland JH, Cooper SM. Osteoarthritis: A review of the cell biology involved and the evidence of reversibility (Management rationally related to known genesis of pathophysiology). Semin Arthritis Rheum. 1984;14:106–133
  20. Schmidt TA, Gastelum NS, Nguyen QT, et al. Boundary lubrication of articular cartilage: role of synovial fluid constituents. Arthritis Rheum. 2007;56:82–89
  21. Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanism of action. Arthritis Res Ther. 2003;5:54–67
  22. Díaz-Gallego L, Prieto JG, Coronel P, et al. Apoptosis and nitric oxide in an experimental model of osteoarthritis in rabbit after hyaluronic acid treatment. J Orthop Res. 2005;23:1370–1376
  23. Smith MM, Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int. 1987;7:113–122
  24. Gotoh S, Miyazaki K, Onaya J, et al. Experimental knee pain model in rats and analgesic effect of sodium hyaluronate (SPH). [Japanese] Nippon Yakurigaku Zasshi. 1988;92:17–27
  25. Aihara S, Murakami N, Ishii R, et al. Effects of sodium hyaluronate on the nociceptive response of rats with experimentally induced arthritis. Nippon Yakurigaku Zasshi. 1992;100:359–365
  26. Gotoh S, Onaya J, Abe M, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993;52:817–822
  27. Moore AR, Willoughby DA. Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action. Int J Tissue React. 1995;17:153–156
  28. Vad V, Sakalkale D, Sculco TP, et al. Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil. 2003;84:1224–1226
  29. Peyron JG, Balasz EA. Preliminary clinical assessment of Na-hyaluronate injection into the human knee. Pathol Biol. 1974;22:731–736
  30. Salk RS, Chang TJ, D'Costa WF, et al. Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bn Jt Surg (Am). 2006;88:295–302
  31. Srejic U, Calvillo O, Kabakibou K. Viscosupplementation: A new concept in the treatment of sacroiliac joint syndrome: A preliminary report of four cases. Reg Anesth Pain Med. 1999;24:84–88
  32. Clarke S, Lock V, Duddy J, et al. Intra-articular hylan G-F 20 (synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK). Knee. 2005;12:57–62
  33. Petrella RJ, Petrella M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol. 2006;33:5
  34. Tachihara H, Kikuchi S, Konno S, et al. Does facet joint inflammation induce radiculopathy? (An investigation using a rat model of lumbar facet joint inflammation). Spine. 2007;32:406–412

 Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org

 This project was funded by an investigator initiated grant awarded by Genzyme Biosurgery.

PII: S1934-1482(09)01364-1

doi: 10.1016/j.pmrj.2009.09.008

PM&R
Volume 1, Issue 10 , Pages 908-915 , October 2009